Ulcerative Colitis Drug Market to Reach USD 12.98 Billion by 2033; The Emergence of Biosimilars Driving the Growth Newark, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The ulcerative colitis drug market focuses on medications used to treat ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD) that primarily...

Ulcerative Colitis Drug Market To Reach USD 10.25 Billion By 2027 | Reports And Data New York, Feb. 03, 2020 (GLOBE NEWSWIRE) -- The global ulcerative colitis drug market is forecast to reach USD 10.25 Billion by 2027, according to a new report by Reports and Data. Ulcerative...